Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States

COVID-19 and resulting mitigation measures in the United States (US) brought about limited access to medical care that has been linked to increases in mental health problems, excessive substance use, and drug overdoses. The increase in co-prescription of benzodiazepines and opioids may indicate popu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug and alcohol dependence 2021-12, Vol.229 (Pt A), p.109176-109176, Article 109176
Hauptverfasser:	de Dios, Constanza, Fernandes, Brisa S., Whalen, Kristine, Bandewar, Shruti, Suchting, Robert, Weaver, Michael F., Selvaraj, Sudhakar
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics, Opioid - therapeutic use Bamboo Behavior change Benzodiazepines Controlled Substances Coronavirus-19 Coronaviruses COVID-19 Drug development Drug Prescriptions Drug use Drugs Generalized additive models Health behavior Health care Health care access Health insurance Health problems Health services Humans Mental disorders Mental health Mitigation Narcotics Opioids Overdose Overdoses Pandemics Prescription drugs Public health SARS-CoV-2 Short Communication Statistical analysis Substance abuse Substance use Telemedicine Therapeutic drug monitoring Tracking United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!